Metabolomic analysis of human disease and its application to the eye
- PMID: 20157358
- PMCID: PMC2816827
- DOI: 10.1007/s12177-009-9038-2
Metabolomic analysis of human disease and its application to the eye
Abstract
Metabolomics, the analysis of the metabolite profile in body fluids or tissues, is being applied to the analysis of a number of different diseases as well as being used in following responses to therapy. While genomics involves the study of gene expression and proteomics the expression of proteins, metabolomics investigates the consequences of the activity of these genes and proteins. There is good reason to think that metabolomics will find particular utility in the investigation of inflammation, given the multi-layered responses to infection and damage that are seen. This may be particularly relevant to eye disease, which may have tissue specific and systemic components. Metabolomic analysis can inform us about ocular or other body fluids and can therefore provide new information on pathways and processes involved in these responses. In this review, we explore the metabolic consequences of disease, in particular ocular conditions, and why the data may be usefully and uniquely assessed using the multiplexed analysis inherent in the metabolomic approach.
Similar articles
-
Metabolic characterization of diabetic retinopathy: An 1H-NMR-based metabolomic approach using human aqueous humor.J Pharm Biomed Anal. 2019 Sep 10;174:414-421. doi: 10.1016/j.jpba.2019.06.013. Epub 2019 Jun 10. J Pharm Biomed Anal. 2019. PMID: 31212142
-
IntLIM: integration using linear models of metabolomics and gene expression data.BMC Bioinformatics. 2018 Mar 5;19(1):81. doi: 10.1186/s12859-018-2085-6. BMC Bioinformatics. 2018. PMID: 29506475 Free PMC article.
-
Metabolomics: the "new clinical chemistry" for personalized neonatal medicine.Minerva Pediatr. 2010 Jun;62(3 Suppl 1):145-8. Minerva Pediatr. 2010. PMID: 21089734 Review.
-
Proteomics and metabolomics characterizing the pathophysiology of adaptive reactions to the metabolic challenges during the transition from late pregnancy to early lactation in dairy cows.J Proteomics. 2018 Apr 30;178:92-106. doi: 10.1016/j.jprot.2017.10.010. Epub 2017 Oct 18. J Proteomics. 2018. PMID: 29055723 Review.
-
Metabolomic findings in sepsis as a damage of host-microbial metabolism integration.J Crit Care. 2018 Feb;43:246-255. doi: 10.1016/j.jcrc.2017.09.014. Epub 2017 Sep 15. J Crit Care. 2018. PMID: 28942199 Review.
Cited by
-
Untargeted metabolomics for uncovering plasma biological markers of wet age-related macular degeneration.Aging (Albany NY). 2021 May 4;13(10):13968-14000. doi: 10.18632/aging.203006. Epub 2021 May 4. Aging (Albany NY). 2021. PMID: 33946050 Free PMC article.
-
A metabolomic approach to dry eye disorders. The role of oral supplements with antioxidants and omega 3 fatty acids.Mol Vis. 2015 May 11;21:555-67. eCollection 2015. Mol Vis. 2015. PMID: 25999682 Free PMC article.
-
A Set of Global Metabolomic Biomarker Candidates to Predict the Risk of Dry Eye Disease.Front Cell Dev Biol. 2020 Jun 8;8:344. doi: 10.3389/fcell.2020.00344. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32582687 Free PMC article.
-
Alpha-crystallin mutations alter lens metabolites in mouse models of human cataracts.PLoS One. 2020 Aug 24;15(8):e0238081. doi: 10.1371/journal.pone.0238081. eCollection 2020. PLoS One. 2020. PMID: 32833997 Free PMC article.
-
Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopia.Front Mol Biosci. 2024 Aug 13;11:1403844. doi: 10.3389/fmolb.2024.1403844. eCollection 2024. Front Mol Biosci. 2024. PMID: 39193222 Free PMC article. Review.
References
-
- Nordstrom A, Lewensohn R. Metabolomics: moving to the clinic. J Neuroimmune Pharmacol. 2009 doi:10.1007/s11481-009-9156-4. - PubMed
-
- Van der Woude D, Houwing-Duistermaat JJ, Toes RE, Huizinga TW, Thomson W, Worthington J, et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum. 2009;60:916–923. doi: 10.1002/art.24385. - DOI - PubMed
LinkOut - more resources
Full Text Sources